Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

about

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

Item

http://www.wikidata.org/entity/Q47120314

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

@en

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

@nl

type

Item

label

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

@en

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

@nl

prefLabel

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

@en

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

@nl

P1476

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists

@en

P2093

Heitor Moreno

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Yugar-Toledo

http://www.w3.org/2001/XMLSchema#string

Rodrigo Modolo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension

Association of serum parathyrine and calcium levels with primary aldosteronism: a meta-analysis

Obstructive sleep apnea and cardiovascular disease: a perspective and future directions

Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.

Arterial pressure, left ventricular mass, and aldosterone in essential hypertension.

Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.

Human adipocytes secrete mineralocorticoid-releasing factors.

Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study

Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension.

P304

403-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/VHRM.S138599

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ana Paula de Faria

P5008

ScienceSource

P577

2017-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29081661

http://www.w3.org/2001/XMLSchema#string

P921

drug resistance

antimineralocorticoid

arterial hypertension

spironolactone

antihypertensive drug

blood pressure

Renin–angiotensin system

P932

5652936

http://www.w3.org/2001/XMLSchema#string